Rapid weight loss from GLP-1 medications linked to 'Ozempic feet'

Medical discussions surrounding GLP-1 receptor agonists, such as Ozempic, have identified a side effect colloquially termed "Ozempic feet." As reported by Iltalehti citing Healthline, individuals undergoing rapid weight loss may observe noticeable physical changes in their lower extremities. These changes include a bonier appearance of the feet, alterations in shoe size, and localized foot pain. Medical professionals explain that the condition stems directly from the rapid depletion of body fat rather than a specific chemical mechanism of the drug. As GLP-1 treatments grow in popularity globally, physicians are noting how swift body composition changes can unexpectedly affect various anatomical areas.

Sources: Iltalehti